Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
Biomarker
|
disease |
CTD_human |
|
|
|
Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Colorectal Carcinoma
|
0.310 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Hypochromatism
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased mean corpuscular volume
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of metabolism/homeostasis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the liver
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED
|
0.050 |
Biomarker
|
disease |
BEFREE |
<i>In vivo</i>, a significant hypomyelination was found in DMT1 conditional knock-out mice in which DMT1 was postnatally deleted in NG2- or Sox10-positive OPCs.
|
30190412 |
2018 |
Iron deficiency
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
2 and 6 μm ELT increased Tfr1 and Slc11a2 (iron-responsive genes involved in neuronal iron uptake) mRNA levels, indicating neuronal ID.
|
28005311 |
2017 |
Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
GermlineCausalMutation
|
disease |
ORPHANET |
Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2).
|
16160008 |
2006 |
Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2).
|
16160008 |
2006 |
Iron-Refractory Iron Deficiency Anemia
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
Iron-refractory iron deficiency anaemia (IRIDA) is a rare disorder which was linked to mutations in two genes (SLC11A2 and TMPRSS6).
|
22509377 |
2012 |
Microcytic hypochromic anemia (disorder)
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Hypochromic microcytic anemia associated with ineffective erythropoiesis caused by recessive mutations in divalent metal transporter 1 (DMT1) can be improved with high-dose erythropoietin supplementation.
|
22580996 |
2012 |
Iron deficiency
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Nramp2 is an intestinal iron transporter, upregulated by dietary iron deficiency, which also colocalizes with transferrin in recycling endosomes.
|
11042033 |
2000 |
Iron deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
DMT1 and FP1 are centrally involved in iron uptake/transfer in the duodenum and in the adaptive changes of iron homeostasis to iron deficiency and overload.
|
11313311 |
2001 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
CTD_human |
Divalent metal transporter 1 (DMT1) is a transmembrane, proton-coupled metal ion transporter that is upregulated in the duodenum of iron-deficient rodents and in hereditary hemochromatosis patients, suggesting that it may constitute a key factor in the uptake of dietary iron.
|
11439223 |
2001 |
Iron deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
DMT-1 expression in C282Y homozygote subjects is consistent with the hypothesis of a "paradoxical" duodenal iron deficiency in hereditary hemochromatosis.
|
12547214 |
2003 |
Iron deficiency
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
DMT1 protein expression was localized in differentiated enterocytes at the villi tips in controls, whereas with iron deficiency it was observed throughout the villi.
|
15054143 |
2004 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
DMT1 expression was significantly increased in HH patients who had undergone phlebotomy therapy (treated) and in patients with ID compared with controls.
|
15247188 |
2004 |
Iron deficiency
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
DMT1 expression was significantly increased in HH patients who had undergone phlebotomy therapy (treated) and in patients with ID compared with controls.
|
15247188 |
2004 |
Microcytic hypochromic anemia (disorder)
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
DMT1 mutations are responsible for severe hypochromic microcytic anemia in rodents and in 2 human patients described recently.
|
16439678 |
2006 |
Microcytic hypochromic anemia (disorder)
|
0.080 |
Biomarker
|
disease |
BEFREE |
DMT1 deficiency must be considered in the differential diagnosis of microcytic hypochromic anemia observed in the newborn period.
|
18154916 |
2008 |
Parkinson Disease
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
DMT1 polymorphism and risk of Parkinson's disease.
|
21777657 |
2011 |
Intestinal Volvulus
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
DMT1 was highly expressed in adult female and male B. malayi and Onchocerca volvulus.
|
29957332 |
2018 |
Huntington Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A decreasing tendency in the level of TF transcript and increasing tendency of SLC11A2 mRNA encoding DMT1 was observed in the blood of HD patients compared to the control subjects, but neither attained statistical significance.
|
26471164 |
2016 |